Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1619-7089

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent ; day:22 ; month:2 ; year:2021 ; pages:1-14
European journal of nuclear medicine and molecular imaging ; (22.2.2021), 1-14

Creator: Collij, Lyduine E.
Salvadó, Gemma
Shekari, Mahnaz
Lopes Alves, Isadora
Reimand, Juhan
Wink, Alle Meije
Zwan, Marissa
Niñerola-Baizán, Aida
Perissinotti, Andrés
Scheltens, Philip
Ikonomovic, Milos D.
Smith, Adrian P. L.
Farrar, Gill
Molinuevo, José Luis
Barkhof, Frederik
Buckley, Christopher J.
Berckel, Bart N. M. van
Gispert, Juan D.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00259-020-05174-2

URN: urn:nbn:de:101:1-2021050719053985497249

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Collij, Lyduine E.
Salvadó, Gemma
Shekari, Mahnaz
Lopes Alves, Isadora
Reimand, Juhan
Wink, Alle Meije
Zwan, Marissa
Niñerola-Baizán, Aida
Perissinotti, Andrés
Scheltens, Philip
Ikonomovic, Milos D.
Smith, Adrian P. L.
Farrar, Gill
Molinuevo, José Luis
Barkhof, Frederik
Buckley, Christopher J.
Berckel, Bart N. M. van
Gispert, Juan D.
SpringerLink (Online service)

Other Objects (12)

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

The “rights” of precision drug development for Alzheimer’s disease

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer’s disease correlates with pathology

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Diagnostic impact of [18F]flutemetamol PET in early-onset dementia

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

The “rights” of precision drug development for Alzheimer’s disease

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer’s disease correlates with pathology

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Diagnostic impact of [18F]flutemetamol PET in early-onset dementia

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

The “rights” of precision drug development for Alzheimer’s disease

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer’s disease correlates with pathology

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Diagnostic impact of [18F]flutemetamol PET in early-onset dementia

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

The “rights” of precision drug development for Alzheimer’s disease

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer’s disease correlates with pathology

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Diagnostic impact of [18F]flutemetamol PET in early-onset dementia

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

The “rights” of precision drug development for Alzheimer’s disease

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer’s disease correlates with pathology

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Diagnostic impact of [18F]flutemetamol PET in early-onset dementia

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

The “rights” of precision drug development for Alzheimer’s disease

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer’s disease correlates with pathology

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Diagnostic impact of [18F]flutemetamol PET in early-onset dementia

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Related objects

Reset password